John G. Freund - 18 May 2026 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Reporting relationship: Director
Issuer ticker: COLL
Reported as of: 18 May 2026
Net transaction value: -$681
SEC form: 4
Accepted by SEC: 20 May 2026, 16:05:09 UTC
Prior SEC filing: 18 May 2026
Next SEC filing: 08 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Colleen Tupper as Attorney-in-Fact for John G. Freund, MD

Key filing fact

John G. Freund filed Form 4 for COLLEGIUM PHARMACEUTICAL, INC (COLL) on 20 May 2026.

Key facts

This page summarizes John G. Freund's Form 4 filing for COLLEGIUM PHARMACEUTICAL, INC (COLL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 20 May 2026, 16:05.

Change

Previous filing in this sequence was filed on 18 May 2026.
Current net transaction value: -$681.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001296771 Primary reporting owner

Freund John Gordon

Relationship: Director
Address: C/O COLLEGIUM PHARMACEUTICAL, INC., 100 TECHNOLOGY CENTER DRIVE, STOUGHTON
Signature: /s/ Colleen Tupper as Attorney-in-Fact for John G. Freund, MD
Signature date: 20 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

COLL transaction

Common Stock

Sale

Transaction value: $681
Shares: -20
Change %: -0.02%
Price: $34.05
Shares after: 83,952
Date: 18 May 2026
Ownership: Direct

COLL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 23,129
Date: 18 May 2026
Ownership: By: John Freund Family Partnership IV, L.P.
Footnotes: F1

COLL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,625
Date: 18 May 2026
Ownership: By: Skyline Venture Management V, LLC
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares are held by the John Freund Family Partnership IV, L.P. ("Freund LP"). The Reporting Person is the trustee and beneficiary of the The John G. Freund Revocable Trust u/a/d 6/26/01 which serves as the general partner of Freund LP. The Reporting Person disclaims beneficial ownership of the shares held by Freund LP except to the extent of his proportionate pecuniary interest therein.

Footnote F2

The shares are held by Skyline Venture Management V, LLC. John G. Freund and Yasunori Kaneko are managers of Skyline Venture Management V, LLC. These individuals share voting and investment power over the shares held by Skyline Venture Management V, LLC. The Reporting Person disclaims beneficial ownership of all the shares held by Skyline Venture Management V, LLC except to the extent of his proportionate pecuniary interest therein.